about
Prevalence of type 2 diabetes in Nepal: a systematic review and meta-analysis from 2000 to 2014Outcomes of haploidentical transplant compared with matched donor allogeneic stem cell transplant.Same Data; Different InterpretationsBevacizumab in Advanced Cervical Cancer: Issues and Challenges for Low- and Middle-Income Countries.Me, TooCheaper Options in the Prevention of Chemotherapy-Induced Nausea and Vomiting.Pazopanib monotherapy in a patient with a malignant granular cell tumor originating from the right orbit: A case report.Prevalence and correlates of psychological distress symptoms among patients with substance use disorders in drug rehabilitation centers in urban Nepal: a cross-sectional study.Low-value practices in oncology contributing to financial toxicity.Chemotherapy in locally advanced head and neck squamous cell carcinoma.Continuous versus intermittent docetaxel for metastatic castration resistant prostate cancer.Human Trafficking in Nepal: Post-Earthquake Risk and Response.Risk of serious adverse events and fatal adverse events with sorafenib in patients with solid cancer: a meta-analysis of phase 3 randomized controlled trials†.Economics of Cancer Medicines: For Whose Benefit?Prophylactic Use of Antiemetics for Prevention of Opioid-Induced Nausea and Vomiting: A Questionnaire Survey among Japanese Physicians.Muscle wasting associated with the long-term use of mTOR inhibitors.Negative trials in ovarian cancer: is there such a thing as too much optimism?Adoptive cell therapy and modulation of the tumour microenvironment: new insights from ASCO 2016.Cancer drugs in LMICs: cheap but unaffordable.Use of donated clotting factors for surgeries on haemophilic patients in a resource-constrained country: a kind donor, good outcome, change of practice and future directions.The OlympiAD trial: who won the gold?Autologous Transplantation for Newly Diagnosed Multiple Myeloma in the Era of Novel Agent Induction: A Systematic Review and Meta-analysis.Efficacy of Prophylactic Treatment for Oxycodone-Induced Nausea and Vomiting Among Patients with Cancer Pain (POINT): A Randomized, Placebo-Controlled, Double-Blind Trial.Duration of adjuvant trastuzumab in HER2 positive breast cancer: Overall and disease free survival results from meta-analyses of randomized controlled trials.Inspiration amidst the challenges: the first report of successful bone marrow transplantation in the Himalayan country Nepal.Should low-income countries invest in breast cancer screening?Me too-drugs with limited benefits - the tale of regorafenib for HCC.Biosimilars in oncology: everybody agrees but nobody uses?Adjuvant sunitinib for high-risk-resected renal cell carcinoma: a meta-analysis of ASSURE and S-TRAC trials.Ischemic Stroke and Impact of Thyroid Profile at Presentation: A Systematic Review and Meta-analysis of Observational Studies.Socioeconomic and health system factors associated with lower utilization of hematopoietic cell transplantation in older patients with acute myeloid leukemia.The US Food and Drug Administration's Approval of Adjuvant Sunitinib for Renal Cell Cancer: A Case of Regulatory Capture?Pemetrexed in Nonsquamous Non-Small-Cell Lung Cancer: The Billion Dollar Subgroup Analysis.Health policy: Me-too drugs with limited benefits - the tale of regorafenib for HCC.Combining drugs and extending treatment - a PFS end point is not sufficient.Low skeletal muscle density is associated with poor survival in patients who receive chemotherapy for metastatic gastric cancer.FDA Approval Summary: Sonidegib-Letter.Safety and Efficacy of Azathioprine as a Second Line Therapy for Primary Immune Thrombocytopenic Purpura.TKI-induced pure red cell aplasia: first case report of pure red cell aplasia with both imatinib and nilotinib.Opioid-induced constipation.
P50
Q26776359-E0D44DBB-93BB-47C3-907E-2FD75E3F402AQ30240140-3D0211EF-AF24-4D0D-BA78-FD4DB9428B0CQ31125419-153F2EFB-635F-498F-BBC6-18E9F09F3EC5Q33859790-F0B739D6-CD5F-4F33-B1BA-F47351E69715Q33866095-33EED8E8-3E23-4221-8DCE-4D1A96230138Q33866119-E99A9A17-461F-4CE9-987B-F1E93CE358C6Q35870399-196DB69E-866E-40BA-8C13-E826881A6658Q36127452-B58329AE-5065-422D-BF95-6A01179E4885Q37720714-290C8952-17B1-4F53-B255-6326F452F052Q38753994-730332C8-DADF-47DA-9421-AA539DEDF980Q38829201-EAF1C2DD-23F2-4056-A3BD-7315A4D8A0B8Q39167364-5AB62647-D7B1-4F45-B066-F5D84D2E5FC4Q39258192-54A3F6D1-25F8-4AA7-88AA-1735AB4FC0B7Q39314693-2E5CA7D2-429B-4FC9-B4CB-2527CF722D44Q40384402-69DA14FD-5573-4D66-A634-635CF80D5580Q41896035-A68AE120-63AC-48C8-97BA-E0565D0B5F83Q42347314-5AF34052-AC18-41D1-941F-185A991BA091Q42397300-4002112B-C115-4DA0-A916-AB1C8D4F5DE3Q45362505-21948420-4A45-4AD1-B9BD-B0F6DF13F15BQ45855697-4387673F-56D0-4599-85FD-A6A5FA4C6F7FQ47132052-4112D9EC-5A62-4FB7-BFC4-25E4B9B41B42Q47207279-89E46BE5-F3FE-4561-B4F9-D5686675825AQ47741795-AD08E3D4-8469-4142-A958-655E01056576Q47869726-29F8A7AB-FAAE-4A5B-A57B-95229D164E0EQ48142593-21FB30FF-D0C3-4579-9F14-4F4A79D8E41CQ48331830-2E0A93DA-DC0E-4C8D-B345-919786BD4EC4Q49577581-16A44532-B9DA-405F-946A-1E8AD3B37D19Q50644650-05BD46F4-E814-490B-A637-A2FD1DA2EB93Q51072214-F6D825E4-9EF8-4C51-8178-679DB5E52DFCQ52541074-161BE9EC-F95F-4CF4-BD93-9C92DB8A4609Q52723696-3E647DB0-75FC-46E4-B91C-EBE404A99730Q52727655-14333D0F-D742-4F34-AC5B-3A14CA5C605AQ52760941-8D139879-044A-48C2-8F22-FF3DD872C1E6Q53103129-33FC34F3-5795-411D-8D40-1F718BAB53E1Q53110057-52F3AA87-2334-4F9A-8C0A-662E4A4372D3Q53250592-F3804E24-D6D8-4BA0-8F98-97CF0E904E80Q53802657-E22C6928-169E-4896-9EAF-579526A017F0Q53999597-B62E66F6-0E2F-4FDB-9F8D-2EDA2CEF394AQ54162903-1C882C08-CAD5-49BF-A2C4-5D5FCBEE4691Q54262333-E9AC0F7C-7E7D-4034-9701-77277B78E507
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Bishal Gyawali
@ast
Bishal Gyawali
@en
Bishal Gyawali
@es
Bishal Gyawali
@nl
Bishal Gyawali
@sl
type
label
Bishal Gyawali
@ast
Bishal Gyawali
@en
Bishal Gyawali
@es
Bishal Gyawali
@nl
Bishal Gyawali
@sl
prefLabel
Bishal Gyawali
@ast
Bishal Gyawali
@en
Bishal Gyawali
@es
Bishal Gyawali
@nl
Bishal Gyawali
@sl
P106
P1153
56237046200
P2798
P31
P496
0000-0001-7444-8594